Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Some, like Pfizer Inc. Chief Executive Officer Albert Bourla, were in Washington for the inauguration weekend. And within the corporate ranks, there was optimism that the new administration would ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

The company made its debut last year with a $51 million Series A and a licensing agreement with Astellas for a gene therapy candidate (KT430) for X-linked myotubular myopathy. Shortly after that ...

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

The post-pandemic surge in seven-figure earners is over. Here's what factors are contributing to the seven-figure slide.… Each organization received $50,000.… As a managed IT provider ...

Jamie Dimon, the head of Wall Street titan JPMorgan, told staffers that he didn't care about a petition circulating that was trying to reverse the company's latest policy. Forbes Media Chairman ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the genetic defects in the BBS1 gene.

As extreme cold warnings persisted over the weekend, the inside of the Indian & Métis Friendship Centre was heating up for the Prince Albert Winter Festival's annual jigging contest. Over a hundred ...